Fostamatinib

Category: Immune System



Fostamatinib Overview

Fostamatinib, sold under the brand names Tavalisse and Tavlesse, is a medication approved by the U.S. Food and Drug Administration since 2018 and European Medicines Agency since 2020[1] for the treatment of chronic immune thrombocytopenia (ITP). The drug is administered orally as a disodium hexahydrate salt, and is a prodrug of the active compound tamatinib (R-406),[2] which is an inhibitor of the enzyme spleen tyrosine kinase (Syk),[3] hence i...

Read more Fostamatinib Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Fostamatinib

Recent Fostamatinib Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Fostamatinib
  • Tablet: 100mg, 150mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Fostamatinib or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 10 August 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA